Genpact price target lowered to $50 from $55 at Needham

Needham analyst Mayank Tandon lowered the firm’s price target on Genpact (G) to $50 from $55 and keeps a Buy rating on the shares. The company posted solid Q1 results, beating top and bottom line estimates, and added 80 new logos, but the positive print was clouded by a weak Q2 guide and lower FY25 outlook, primarily due to heightened macro uncertainty causing large deal signings to be pushed out post “Liberation Day”, the analyst tells investors in a research note.